We are live on
!
Find out more
PR
Payden & Rygel Portfolio holdings
AUM
$1.3B
1-Year Est. Return
28.32%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.21B
AUM Growth
-$1.88M
(-0.16%)
Cap. Flow
-$98.4M
Cap. Flow
% of AUM
-8.16%
Top 10 Holdings %
Top 10 Hldgs %
29.75%
Holding
126
New
13
Increased
20
Reduced
44
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$17.9M |
| 2 |
Valero Energy
VLO
|
+$16.7M |
| 3 |
Analog Devices
ADI
|
+$16.4M |
| 4 |
Merck
MRK
|
+$16M |
| 5 |
Chevron
CVX
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$25.9M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$18.1M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$15.9M |
| 4 |
Danaher
DHR
|
+$15.6M |
| 5 |
HCA Healthcare
HCA
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.47% |
| 2 | Technology | 14.69% |
| 3 | Healthcare | 11.02% |
| 4 | Industrials | 9.65% |
| 5 | Communication Services | 7.4% |
Similar funds
GPCM
PWP
MCM
SPC
HCS
MB
SP
CCFM
Payden & Rygel's Q3 2025 Portfolio in Review
As of Q3 2025, Payden & Rygel held 126 positions worth $1.21B, down 0.16% from $1.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Payden & Rygel withdrew a net $98.4M in Q3 2025, closing 13 positions and reducing 44 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $15.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Payden & Rygel opened a new position in CVS Health worth $19.7M.
- Payden & Rygel's largest Q3 2025 buy was CVS Health: 261,500 shares worth $19.7M.
- Payden & Rygel added most to Merck in Q3 2025, an estimated $16M increase.
- Payden & Rygel's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $25.9M.
- Payden & Rygel fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $15.9M.
- Payden & Rygel's ten largest holdings make up 30% of its $1.21B portfolio in Q3 2025.
- Payden & Rygel opened 13 new positions and closed 13 in Q3 2025.
- Payden & Rygel's portfolio value fell 0.16% quarter-over-quarter to $1.21B.
Based on Payden & Rygel's 13F filing for Q3 2025, filed 10 Nov 2025.